Maggie Simpson

Listen to #ACNAP CardioTalk a podcast series @escardio.bsky.social
Join leading allied professionals as they explore their roles, responsibilities & innovations across the #cardiovascular care pathway
Empowering conversations from practice to impact
🔗 Listen here: esc365.escardio.org/results?query&…

Great cause but the messaging around the blood test is wrong

#cardiosky

🚨 New from @escardio.bsky.social #Aorticare free eLearning module designed to improve:
🩺diagnosis
➡️referral
🫀management
of patients with #aorticstenosis
Gain insights into pathophysiology, assessment, intervention & follow-up
For HCP involved in management of AS
🔗escelearning.escardio.org/course/72

#Aspirin delays #preeclampsia in women with chronic #hypertension

#CardioObstetrics #CardioSky @acog.org
www.ajog.org/article/S000...
@preeclampsia.org @abraguo.bsky.social @drmarthagulati.bsky.social @m4ggiesimp.bsky.social @garimasharmamd.bsky.social @mdharringtonc.bsky.social

Trump Pardoned Tax Cheat After Mother Attended $1 Million Dinner

Trump math: $1M dinner + lots of kissing up = 1 pardon + erasing a $4.4M penalty.

To Trump, it doesn't matter that Walczak stole millions from the paychecks of nurses and doctors to pay for a yacht. All that matters is how much money his family paid Trump.

Menopause matters in #cardiovascular health 🫀

A new @jaccjournals.bsky.social calls for better clinical training to manage cardiometabolic risks during the menopausal transition

Multidisciplinary care & education are key

Read more: jacc.org/doi/10.1016/j.… #WomensHeartHealth #CVD #cardiosky

@leeannemacklin.bsky.social

New framework sets standard for Cardiology Nurse Specialists Today marks an important milestone with the launch of Scotland’s first national framework for Specialist Nursing in Cardiology. Unveiled at Forth Valley Royal Hospital, the Framework aims to standardi...

📢 Scotland launches its first Specialist Nursing in #Cardiology Framework, setting national standards for cardiology nurse specialists. A significant step towards consistent, high-quality cardiac care across the country

Read more: snapca.co.uk/news/f/new-f...

#Cardiology #CNSvalue #CardioSky

#cardiosky

Join us tomorrow for the HFA Journal Club as we dive into the Win Ratio in #HF trials! 🏆💖

🗓 24 March 2025
🕕 18:00–19:00 CET

✨ Explore the win ratio & its impact
🔍 EMPULSE trial insights
💬 Ask questions live!

📲 click here: esc365.escardio.org/event/1938

@escardio.bsky.social @jozinetm.bsky.social

How to handle polypharmacy in #heartfailure A clinical consensus statement of the Heart Failure Association @escardio.bsky.social
A rational, pragmatic & multidisciplinary approach to drug prescription in the current era of multi-morbidity & multi-medication in HF
doi.org/10.1002/ejhf.3…
#cardiosky

Announcing the new cardiac amyloidosis diagnostic pathway in Scotland - Heart Failure Hub Heart failure can be a complex condition with many underlying causes, one of which is cardiac amyloidosis (CA). CA is a rare but increasingly recognised cause

Announcing the new cardiac amyloidosis diagnostic pathway in Scotland. Together, we can enhance early recognition, improve patient outcomes, and raise awareness of this often-overlooked condition

www.heartfailurehubscotland.co.uk/announcing-t...

Heart Failure: A Century View, From Failure to Function

www.ahajournals.org/doi/10.1161/...

@ahajournals.bsky.social
#CardioSky #MedSky #Cardiology #HeartFailure #AHAJournals #Circulation

Ubiquity of Multimorbidity: Comorbid Conditions and Mortality in HFpEF.

www.ahajournals.org/doi/10.1161/...

@ahajournals.bsky.social
#CardioSky #MedSky #Cardiology #CircHeartFailure #HeartFailure #AHAJournals

Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysis Background Atrial fibrillation (AF) prevalence is rising due to population ageing and comorbidity is an increasing problem. The aim of this study was to examine the prevalence and association of coexi...

Our new study in Heart is a large-scale characterisation of conditions prevalent and associated with atrial fibrillation.

#cardiosky #medsky #GPsky

heart.bmj.com/content/earl...

In the HELIOS-B trial, researchers assessed the efficacy and safety of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the results. Full trial: nej.md/3X5nl5Q

#MedSky #CardioSky @cpkotanidis.bsky.social

An illustration of the mechanism of Danon disease.

The authors of a new editorial describe the foundations of a study of gene therapy to treat children and young adults with Danon disease. Read the full editorial: nej.md/4irkBsB

#MedSky #CardioSky #Genetics

Just a few tickets left for @BHFScotland national conference for HCP with an interest in CVD
A great programme has been organised covering latest in practice, research, policy and pilot projects to improve outcomes for people living with CVD #cardiosky
Register free: eventbrite.co.uk/e/bhf-scotland…

Unlock your potential with the 2025 Mentorship Awards! 🌟

Gain personalized mentorship, networking opportunities, & hands-on research experience with top professionals in our community.

Applications open until March 7: womenasone.org/awards-and-g...

#WomenAsOneAwards #WIC #CardioSky

European Journal of HF editorial: The expanding role of #heartfailure nurses: A call for harmonized standards across Europe doi.org/10.1002/ejhf...

Examining the clinical role and educational preparation of heart failure nurses across Europe doi.org/10.1002/ejhf...

#CardioSky

Current guidelines for primary prev ICD might not apply to contemporary pts given advances in HF Rx. Or do they?

🌟 This joint publication in #JCF & @hrs_journal summarizes data to date and proposes clinical trial to reassess.

🔗 bit.ly/3CEUj7a

It just gets worse and worse

Yellow background. Different CDC websites that have been removed. Some are in black and white. Others are purple or red and green.

✨PLEASE SHARE! CDC GUIDELINE ARCHIVES✨

▶️STI GUIDELINES
buff.ly/4jReLT4
buff.ly/3EmjR9B

▶️Medical Eligibility Criteria (MEC) for Contraceptives buff.ly/3PZzQNf
buff.ly/4aKMEko

▶️VACCINE VIS buff.ly/4jJ1603

▶️Others from @jessicavalenti.bsky.social
LGBTQ CDCGuidelines.com

#medsky #pedsky #IDsky 🛟🧪

Transitioning from pediatric to adult CV care teams is a stressful & high-risk time for patients.

@elenadonaldMD discusses the need for disease-specific transition programs to help support & guide emerging adults & caregivers in this vulnerable phase

🔗https://bit.ly/4gV3izU

The @hfhubscotland.bsky.social website has been updated to reflect the new work streams of the Hub & will host more information on models of care, trials recruiting & HF guidance, education & events

heartfailurehubscotland.co.u
#cardiosky

@ACNAPPresident Nurses & allied professionals’ engagement in clinical research-in-practice

NAP clinical practice should be research-informed & based on the best available evidence

What are the barriers & how can we overcome them?

doi.org/10.1093/eurjcn…
#cardiosky

Patient & public perspectives of involvement in CV research in🏴󠁧󠁢󠁳󠁣󠁴󠁿

Engage with underrepresented populations
Articulate value of PPI
Ensure sufficient PPI costs in funding applications
Read more here:
dx.doi.org/10.5837/bjc.20…
@SheonaMchale @AlicePearsons @HansonCoral @lisneubeck @MaryMcAuley5

Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program | Circulation: Heart Failure BACKGROUND: Mavacamten is the only cardiac myosin inhibitor approved by the U.S. Food and Drug Administration for the treatment of patients with symptomatic New York Heart Association class II–III obs...

Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program
www.ahajournals.org/doi/10.1161/...

Registration for our 2025 patient & carer event is now open www.eventbrite.com/e/heart-fail...

Please share with your networks #heartfailure